Nymox Pharmaceutical has announced the Immunogenicity results for its drug candidate NX-1207 BPH Program, which has not shown any evidence of eliciting an immune reaction in men treated with intraprostatic injections of the drug. NX-1207 ...
Tags: Nymox Pharmaceutical, Immunogenicity results, NX-1207 BPH Program
SQI Diagnostics has introduced SQiDlite multiplexing system for pharmaceutical drug development and contract research organizations performing bioanalytical and immunogenicity testing. The SqiDlite system, which can run on the company's ...
Tags: SQI Diagnostics, SQiDlite multiplexing system, immunogenicity testing